IL161296A0 - Glycosylphosphatidylinositol containing polypeptides - Google Patents

Glycosylphosphatidylinositol containing polypeptides

Info

Publication number
IL161296A0
IL161296A0 IL16129602A IL16129602A IL161296A0 IL 161296 A0 IL161296 A0 IL 161296A0 IL 16129602 A IL16129602 A IL 16129602A IL 16129602 A IL16129602 A IL 16129602A IL 161296 A0 IL161296 A0 IL 161296A0
Authority
IL
Israel
Prior art keywords
polypeptides
glycosylphosphatidylinositol
containing polypeptides
relates
domain
Prior art date
Application number
IL16129602A
Other languages
English (en)
Original Assignee
Asterion Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0124620A external-priority patent/GB2380735A/en
Priority claimed from GB0200904A external-priority patent/GB0200904D0/en
Priority claimed from GB0218889A external-priority patent/GB0218889D0/en
Application filed by Asterion Ltd filed Critical Asterion Ltd
Publication of IL161296A0 publication Critical patent/IL161296A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Transplantation (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Orthopedic Medicine & Surgery (AREA)
IL16129602A 2001-10-13 2002-10-11 Glycosylphosphatidylinositol containing polypeptides IL161296A0 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0124620A GB2380735A (en) 2001-10-13 2001-10-13 GPI-anchored proteins
GB0200904A GB0200904D0 (en) 2002-01-16 2002-01-16 Anchors-2
GB0218889A GB0218889D0 (en) 2002-08-14 2002-08-14 Anchors 3
PCT/GB2002/004665 WO2003034275A2 (en) 2001-10-13 2002-10-11 Chimeric glycosylphosphatidylinositol containing peptides

Publications (1)

Publication Number Publication Date
IL161296A0 true IL161296A0 (en) 2004-09-27

Family

ID=27256298

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16129602A IL161296A0 (en) 2001-10-13 2002-10-11 Glycosylphosphatidylinositol containing polypeptides

Country Status (17)

Country Link
US (1) US7485713B2 (zh)
EP (1) EP1446733B1 (zh)
JP (1) JP4384492B2 (zh)
KR (2) KR20100039911A (zh)
CN (1) CN1568330A (zh)
AT (1) ATE442444T1 (zh)
AU (1) AU2002334161B2 (zh)
CA (1) CA2494706A1 (zh)
DE (1) DE60233674D1 (zh)
DK (1) DK1446733T3 (zh)
ES (1) ES2329228T3 (zh)
HU (1) HUP0401611A3 (zh)
IL (1) IL161296A0 (zh)
NZ (1) NZ532460A (zh)
PL (1) PL369953A1 (zh)
PT (1) PT1446733E (zh)
WO (1) WO2003034275A2 (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080073293A (ko) 2005-10-14 2008-08-08 메디뮨 엘엘씨 항체 라이브러리의 세포 디스플레이
ES2526079T3 (es) * 2005-12-20 2015-01-05 Sbi Biotech Co., Ltd. Anticuerpo anti-ILT7
WO2007098547A1 (en) * 2006-03-01 2007-09-07 Apollo Life Sciences Limited A molecule and chimeric molecules thereof
GB0618082D0 (en) * 2006-09-14 2006-10-25 Asterion Ltd Growth factor
WO2008100816A2 (en) * 2007-02-09 2008-08-21 Medimmune, Llc Antibody libray display by yeast cell plasma membrane
CN103694337B (zh) * 2008-02-08 2016-03-02 Ambrx公司 经修饰瘦素多肽和其用途
JP6542197B2 (ja) 2013-04-12 2019-07-10 エヴォックス・セラピューティクス・リミテッド 治療的送達小胞

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5374548A (en) * 1986-05-02 1994-12-20 Genentech, Inc. Methods and compositions for the attachment of proteins to liposomes using a glycophospholipid anchor
US4857637A (en) * 1986-05-07 1989-08-15 Genentech, Inc. Methods and compositions for immunologically modulating growth hormone receptor activity
US5057417A (en) * 1987-06-12 1991-10-15 Genentech, Inc. Compositions and methods for the synthesis of growth hormone receptor and growth hormone binding protein
US6113917A (en) * 1995-04-25 2000-09-05 Rmf Dictagene S.A. Modified polypeptides for enhanced immunogenicity
TW562807B (en) * 1997-04-01 2003-11-21 Chugai Pharmaceutical Co Ltd Novel secretory membrane protein
CA2294704A1 (en) * 1997-06-26 1999-01-07 Immunex Corporation Protein that binds trail
EP1081224B1 (en) * 1998-05-20 2006-06-07 Chugai Seiyaku Kabushiki Kaisha Novel method for cloning a gene
JP2002542771A (ja) * 1999-03-24 2002-12-17 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド ヒト腫瘍壊死因子レセプターｔｒ９
JP3815409B2 (ja) * 2002-08-29 2006-08-30 ブラザー工業株式会社 電話端末、通話システムおよび端末制御プログラム

Also Published As

Publication number Publication date
NZ532460A (en) 2005-10-28
EP1446733B1 (en) 2009-09-09
PL369953A1 (en) 2005-05-02
JP4384492B2 (ja) 2009-12-16
JP2005505307A (ja) 2005-02-24
AU2002334161B2 (en) 2007-03-29
WO2003034275A3 (en) 2003-11-27
DE60233674D1 (de) 2009-10-22
CA2494706A1 (en) 2003-04-24
EP1446733A2 (en) 2004-08-18
KR20100039911A (ko) 2010-04-16
HUP0401611A2 (hu) 2004-11-29
US20050059577A1 (en) 2005-03-17
DK1446733T3 (da) 2009-10-26
KR20050035511A (ko) 2005-04-18
ATE442444T1 (de) 2009-09-15
CN1568330A (zh) 2005-01-19
WO2003034275A2 (en) 2003-04-24
PT1446733E (pt) 2009-09-28
HUP0401611A3 (en) 2010-01-28
ES2329228T3 (es) 2009-11-24
US7485713B2 (en) 2009-02-03

Similar Documents

Publication Publication Date Title
YU19903A (sh) Novi receptor nukleinskih kiselina i polipeptida
IL226717A (en) Isolated nucleic acids encoded by anti-beta human antibodies 7
WO1996034107A3 (en) Antiviral proteins, dna coding sequences therefor, and uses thereof
WO2005005462A3 (en) Blys antagonists and uses thereof
WO2002089738A3 (en) Proteomimetic compounds and methods
DK0970207T3 (da) Heregulin-varianter
CY1112101T1 (el) Νευροτροφικοι παραγοντες
TR200102191T2 (tr) HER-2/neu füzyon proteinleri.
WO2003104425A3 (en) NEW STABLE ANTI-CD22 ANTIBODIES
WO2004046365A3 (en) Interferon-alpha polypeptides and conjugates
EP1141286A4 (en) CYTOKINE RECEPTOR CHAIN
IL161296A0 (en) Glycosylphosphatidylinositol containing polypeptides
AU7216498A (en) Inhibitors of the urokinase receptor
TR200102655T2 (tr) Dört L. infantum proteininin antijen belirleyicilerini kodlayan kimerik gen.
WO2003018756A3 (en) Methods for preparing purified prostaglandin e synthase
IL162601A0 (en) Raf/ras binding proteins, their preparation and use
EP0897011A3 (en) Novel arginine deiminase
SG148195A1 (en) Plasmids coding for p185neu protein sequence variants and therapeutic uses thereof
WO2001070768A3 (en) Receptor-binding compounds and method for identifying them
EP0885965A3 (en) Histidine kinase polypeptides
EP0892059A3 (en) Histidine kinase polypeptides
WO1999029719A3 (en) Pancreatic-derived factors, and uses related thereto
WO2002047711A3 (en) Modulators of activity of g-protein-coupled receptor kinases
IL152232A0 (en) Promoter to il-18bp, its preparation and use
DE50206254D1 (de) Pna-konjugat zur therapie der chronischen myeloischen leukämie (cml)

Legal Events

Date Code Title Description
MM9K Patent not in force due to non-payment of renewal fees